350 related articles for article (PubMed ID: 15491498)
1. Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats.
Yang B; Brown KK; Chen L; Carrick KM; Clifton LG; McNulty JA; Winegar DA; Strum JC; Stimpson SA; Pahel GL
BMC Pharmacol; 2004 Oct; 4():23. PubMed ID: 15491498
[TBL] [Abstract][Full Text] [Related]
2. PPARgamma agonists diminish serum VEGF elevation in diet-induced insulin resistant SD rats and ZDF rats.
Yang B; Lin P; Carrick KM; McNulty JA; Clifton LG; Winegar DA; Strum JC; Stimpson SA; Pahel GL
Biochem Biophys Res Commun; 2005 Aug; 334(1):176-82. PubMed ID: 15993383
[TBL] [Abstract][Full Text] [Related]
3. Changes of skeletal muscle adiponectin content in diet-induced insulin resistant rats.
Yang B; Chen L; Qian Y; Triantafillou JA; McNulty JA; Carrick K; Clifton LG; Han B; Geske R; Strum J; Brown KK; Stimpson SA; Pahel G
Biochem Biophys Res Commun; 2006 Mar; 341(1):209-17. PubMed ID: 16414018
[TBL] [Abstract][Full Text] [Related]
4. Activation of PPARgamma enhances myocardial glucose oxidation and improves contractile function in isolated working hearts of ZDF rats.
Golfman LS; Wilson CR; Sharma S; Burgmaier M; Young ME; Guthrie PH; Van Arsdall M; Adrogue JV; Brown KK; Taegtmeyer H
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E328-36. PubMed ID: 15797988
[TBL] [Abstract][Full Text] [Related]
5. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
[TBL] [Abstract][Full Text] [Related]
6. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
7. Osthole ameliorates insulin resistance by increment of adiponectin release in high-fat and high-sucrose-induced fatty liver rats.
Qi Z; Xue J; Zhang Y; Wang H; Xie M
Planta Med; 2011 Feb; 77(3):231-5. PubMed ID: 20717873
[TBL] [Abstract][Full Text] [Related]
8. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
Reifel-Miller A; Otto K; Hawkins E; Barr R; Bensch WR; Bull C; Dana S; Klausing K; Martin JA; Rafaeloff-Phail R; Rafizadeh-Montrose C; Rhodes G; Robey R; Rojo I; Rungta D; Snyder D; Wilbur K; Zhang T; Zink R; Warshawsky A; Brozinick JT
Mol Endocrinol; 2005 Jun; 19(6):1593-605. PubMed ID: 15831517
[TBL] [Abstract][Full Text] [Related]
9. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
Ding SY; Shen ZF; Chen YT; Sun SJ; Liu Q; Xie MZ
Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone reverses down-regulation of cardiac PPARgamma expression in Zucker diabetic fatty rats.
Pelzer T; Jazbutyte V; Arias-Loza PA; Segerer S; Lichtenwald M; Law MP; Schäfers M; Ertl G; Neyses L
Biochem Biophys Res Commun; 2005 Apr; 329(2):726-32. PubMed ID: 15737646
[TBL] [Abstract][Full Text] [Related]
11. GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats.
Chen L; Yang B; McNulty JA; Clifton LG; Binz JG; Grimes AM; Strum JC; Harrington WW; Chen Z; Balon TW; Stimpson SA; Brown KK
J Pharmacol Exp Ther; 2005 Feb; 312(2):718-25. PubMed ID: 15475592
[TBL] [Abstract][Full Text] [Related]
12. Effects of cevoglitazar, a dual PPARalpha/gamma agonist, on ectopic fat deposition in fatty Zucker rats.
Laurent D; Gounarides JS; Gao J; Boettcher BR
Diabetes Obes Metab; 2009 Jun; 11(6):632-6. PubMed ID: 19175377
[TBL] [Abstract][Full Text] [Related]
13. Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model.
Sharabi Y; Oron-Herman M; Kamari Y; Avni I; Peleg E; Shabtay Z; Grossman E; Shamiss A
Am J Hypertens; 2007 Feb; 20(2):206-10. PubMed ID: 17261469
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitization with a peroxisome proliferator-activated receptor γ agonist prevents adrenocortical lipid infiltration and secretory changes induced by a high-sucrose diet.
Martinez Calejman C; Di Gruccio JM; Mercau ME; Repetto EM; Astort F; Sanchez R; Pandolfi M; Berg G; Schreier L; Arias P; Cymeryng CB
J Endocrinol; 2012 Sep; 214(3):267-76. PubMed ID: 22700193
[TBL] [Abstract][Full Text] [Related]
15. High-fat- and lipid-induced insulin resistance in rats: the comparison of glucose metabolism, plasma resistin and adiponectin levels.
Li L; Yang G; Li Q; Tang Y; Li K
Ann Nutr Metab; 2006; 50(6):499-505. PubMed ID: 17191023
[TBL] [Abstract][Full Text] [Related]
16. The insulin sensitizing effects of PPAR-γ agonist are associated to changes in adiponectin index and adiponectin receptors in Zucker fatty rats.
Pita J; Panadero A; Soriano-Guillén L; Rodríguez E; Rovira A
Regul Pept; 2012 Feb; 174(1-3):18-25. PubMed ID: 22120832
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin: a relevant player in PPARgamma-agonist-mediated improvements in hepatic insulin sensitivity?
Bouskila M; Pajvani UB; Scherer PE
Int J Obes (Lond); 2005 Mar; 29 Suppl 1():S17-23. PubMed ID: 15711577
[TBL] [Abstract][Full Text] [Related]
18. Effects of PPARgamma and PPARalpha agonists on serum leptin levels in diet-induced obese rats.
Törüner F; Akbay E; Cakir N; Sancak B; Elbeg S; Taneri F; Aktürk M; Karakoç A; Ayvaz G; Arslan M
Horm Metab Res; 2004 Apr; 36(4):226-30. PubMed ID: 15114521
[TBL] [Abstract][Full Text] [Related]
19. A novel PPARalpha agonist ameliorates insulin resistance in dogs fed a high-fat diet.
Tsunoda M; Kobayashi N; Ide T; Utsumi M; Nagasawa M; Murakami K
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E833-40. PubMed ID: 18212024
[TBL] [Abstract][Full Text] [Related]
20. Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes and SD rats.
Lv Q; Wang Y; Wang W; Wang L; Zhou X
Endocr Res; 2009; 34(4):130-41. PubMed ID: 19878073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
